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Background: The initiation of a pregnancy is a process that requires adequate energetic support. Recent
observations at our Institution suggest a central role of magnesium in this situation. The aim of this study
was to evaluate magnesium, zinc, selenium and thyroid function as well as anti-Müllerian hormone in early
pregnancy following in-vitro fertilization as compared to spontaneous successful pregnancies.
Results:A successful outcome of pregnancy after IVF treatmentwas associatedwith 2 parameters: higher levels of
anti-Müllerian hormone as well as higher levels of magnesium in the pre-stimulation blood sample. These two
parameters, however, showed no correlation. Spontaneous pregnancies as well as pregnancies after IVF show a
fall of magnesium levels at 2–3 weeks of gestation. This drop of magnesium concentration is larger following
IVF as compared to spontaneous pregnancies. Parallel to these changes TSH levels showed an increase in early
IVF-pregnancy. At this time point we also observed a positive correlation between fT4 and TSH. This was not
observed in spontaneous pregnancies. Thyroid antibodies showed no correlation to outcomes.
Conclusions: In connection with the initiation of pregnancy following ovarian stimulation dynamic changes of
magnesium and TSH levels can be observed. A positive correlation was found between fT4 and TSH in IVF
pregnancies. In spontaneous pregnancies smaller increases of TSH levels are related to highermagnesium levels.
General signiﬁcance:We propose that magnesium plays a role in early pregnancy as well as in pregnancy success
independently from anti-Müllerian hormone. Neither thyroid hormones nor thyroid antibodies were related to
outcome.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In general physiological terms the metabolic needs during pregnan-
cy are determined by a higher energetic output due to the development
and growth of the fetus [1]. Historical accounts tell about an increase of
thyroid volume during early pregnancy which can be interpreted as a
correlate to an increased need of thyroid hormones [2]. Thyroid function
plays an important role in this context since its actions are involved in
energy delivery through mitochondrial processes [3,4]. The exact role
of thyroid function in infertility and pregnancy, however, has been
debated since decades. Some of the ﬁrst modern investigations on this
topic which included determinations of thyroid function parameters,
i.e. protein-bound iodine (PBI), were published in 1948 [5]. The past
decades have witnessed many opinions and inconclusive results.
The utility and importance of an evaluation of thyroid function in
the sensible area of assisted reproductive technology (ART) treatments,
e.g. in-vitro fertilization (IVF), is also amatter of discussion. In hypothy-
roidism, the delivery rate after IVF has been described as not optimal
even when the patients were receiving substitution treatment [6]. A. This is an open access article underrecent study by Mintziori et al. has questioned the relevance of recom-
mended TSH levels as well as that of thyroid serology on the outcome
of IVF [7]. Gracia et al. have described signiﬁcant changes of fT4 and
TSH following ART, however they recognized that the results needed
to be compared to those which could be found in women attempting
pregnancy without assistance [8]. Reinblatt et al. have investigated the
relation of estradiol levels to TSH levels following ART [9]. The authors
showed that TSH does not change signiﬁcantly during the course of
IVF treatment. One limitation of this study, as stated by the authors,
was that fT4 levels were not measured. A similar situation can be
found in the study by Benaglia et al. [10].
Next to thyroid function estrogen action is also necessary in early
pregnancy. On the molecular level estradiol binding to its receptor re-
quires magnesium [11]. Experimental data has shown that the addition
of selenium to cultured granulosa cells will increase estradiol produc-
tion [12]. Estrogens can inhibit iodine release from the thyroid [13],
thus there could be a physiological mechanism that explains why TSH
increases.
Three recent studies at our Institution have demonstrated magne-
sium deﬁciency as a common central biochemical alteration associated
with either hypothyroidism [14] or hyperthyroidism [15] as well as
with thyroid morphology [16]. Magnesium deﬁciency is also related tothe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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components together with adequate magnesium supplementation,
e.g. magnesium citrate, thyroid function can improve. At the same
time thewell-being of the patients is improved. Some cases will also re-
quire selenium and coenzyme Q10 supplements. On physiological
terms, our model of benign thyroid disease considers magnesium deﬁ-
ciency as a condition that leads tomitochondrial dysfunction by altering
the functional integrity of Complex V of oxidative phosphorylation
(OXPHOS). This alteration can result in less energy availability which
is most commonly expressed as fatigue.
The role of magnesium in pregnancy has been a matter of investiga-
tion since decades. In 1930 Coons and Blunt described a negative mag-
nesium balance toward the end of pregnancy [17]. Hurley, Cosens and
Theriault described in 1976 teratogenic effect of magnesium deﬁciency
in rats [18]. Experiments conducted by Wang et al. demonstrated
adverse effects of magnesium deﬁciency on pregnancy outcome [19].
The animals put on a low magnesium diet had a high incidence of still
births as well as a high incidence of mortality of live offspring in the
post-partum period. If magnesium deﬁciency was introduced during
lactation, the offspring had low serum and carcass magnesium values.
Magnesiumdepletion during lactation also affected themothers. An ad-
ditional factor that can potentiate embryotoxic effects of magnesium
deﬁciency is stress [20]. In the human setting we have demonstrated
that stress inﬂuences the quality of life of patients with hypothyroidism
while at the same time increased stress scores correlate with lower
magnesium levels [14].
Following these introductory lines of thoughtwedesigned this study
with the aim to analyze thyroid function parameters (fT3, fT4, TSH) and
thyroid antibodies together with determinations of serum magnesium,
zinc, selenium, and anti-Müllerian hormone (AMH) in patients under-
going IVF procedures. Data were collected prior to pregnancy as well
during early pregnancy. Cases of spontaneous successful pregnancies
were taken as a control group.
2. Materials and methods
This observational study was based on the clinical data obtained at
our Institution (WOMED Therapiezentrum Kinderwunsch GmbH,
Innsbruck, Austria) in the time period 2005–2012. All clinical proce-
dures were conducted observing the guidelines of the Declaration of
Helsinki [21]. Since the beginning of our clinical work in 2002 emphasis
has been put on diagnostic procedures that included determinations
of micronutrients and metals as well as a full evaluation of thyroid
function [22] and thyroid ultrasound [23].
The discriminating characteristic for the study cohorts was the
successful outcome of pregnancy. A successful pregnancy (IVF-pos.)
was the result of either IVF or IVF following intra-cytoplasmatic sperm
injection (ICSI) (n = 78). A control group with negative outcome after
IVF (IVF-neg.; n=38), in spite of having had class A embryos at embryo
transfer [24], was included. These two groups were compared with
women who had a successful spontaneous pregnancy (n = 28).
In all patients' biochemical data at a pre-pregnancy state was avail-
able. In the IVF group a second sample was also taken at the beginning
of pregnancy, i.e. app. 2–3 weeks after embryo transfer. A sequential
sample was also available at an early time of spontaneous pregnancy,
i.e. the day when the pregnancy test was carried out, as well as in the
3rd trimester. The laboratory determinations included: fT3, fT4, TSH,
thyroid antibodies, magnesium, zinc, selenium, FSH, hCG and estradiol
as well as anti-Müllerian hormone. All determinations were carried
out at a local laboratory facility (Labor Philadelphy, Innsbruck, Austria,
http://www.phillab.at/).
Statistical analysis was done using IBM-SPSS version 21. Sequential
data from the same patients were compared using Student's paired
t-test. Data from the 3 groups were compared using ANOVA. A result
was called signiﬁcant if the p-value was b0.05. Graphical data presenta-
tion was done using the box plot procedure.3. Results
3.1. IVF characteristics
The mean age of the patients in the three study groups were: IVF-
pos. 33.1 ± 4.1, IVF-neg. 34.3 ± 4.5, and spontaneous pregnancy
30.8 ± 5.2 years. Among all patients who required ART the number of
previous pregnancies was as follows: 22 patients had 1, 3 had 2, and 1
patient had had 4 pregnancies. The number of follicles, the quality of
follicles, as well as the number of oocytes did not differ between the
IVF-pos. and IVF-neg. groups. In the IVF-pos. groups 2 patients received
Gonal F® (Follitropin alfa), 41 patients had a long stimulation protocol,
and 28 patients, a short stimulation protocol. In the IVF-neg. group 19
patients underwent a long stimulation protocol and 17 a short protocol.
In the IVF-pos. groups 45 patients underwent IVF, 25 patients had ICSI,
and 3 patients had testicular sperm extraction (TESE). In the IVF-neg.
group the corresponding values were 23, 12, and 2 respectively. None
of these basal characteristics showed any correlation to thyroid param-
eters, nor magnesium.
3.2. Laboratory parameters previous to stimulation or pregnancy
Basal thyroid function parameters, fT3, fT4 and TSH, did not differ
between the 3 study groups. This was also observed for zinc, and seleni-
um. In both IVF groups TSH values showed no correlation to either age,
number of follicles or fertilization procedure (Fig. 1).
Thepercentage of positiveﬁndings for thyroid peroxidase antibodies
was: 20.8% in IVF-pos., 12.9% in IVF-neg., and 15.4% in spontaneous
pregnancies. The corresponding values for elevated anti-thyroglobulin
antibodies were: 13.2%, 6.3%, and 15.4%, respectively.
Serum levels of magnesium were higher in the IVF-pos. group
compared to IVF-neg. group: 0.95 ± 0.06 vs. 0.93 ± 0.06 mmol/l, re-
spectively (p b 0.05) (Fig. 2). This was also observed when spontaneous
pregnancies were compared to the IVF-neg. group: 0.95 ± 0.05 vs.
0.93 ± 0.06 mmol/l respectively (p b 0.05).
In connection to the IVF treatment we did not observe any relation
between magnesium concentration and the number of follicles, nor
the number of oocytes retrieved. Patients having either IVF or ICSI had
similar magnesium levels. The AMH levels prior to stimulation were
higher in the IVF-pos group as compared to the IVF-neg group: 36 ±
23.8, vs. 13 ± 19.2 pmol/l, respectively (p = 0.018).
3.3. Sequential parameters during early pregnancy
Table 1 shows the results for the relevant parameters.
3.3.1. Estradiol levels following IVF
Estradiol levels were higher in the IVF-pos group as compared to the
IVF-neg group, 1527±1256.28, vs. 578.38± 487.57 pmol/l, respective-
ly (p = 0.074) (Fig. 3).
3.3.2. Thyroid function tests
In women with spontaneous pregnancies a slight drop in the con-
centration of TSH was observed (p = n.s.). In contrast to this situation
therewas a rise of TSH levels in the IVF-pos. group in the second sample:
1.47± 0.69 vs. 2.19± 1.56mIU/l, respectively (p b 0.001). In the IVF-
pos. group with a positive thyroid peroxidase (TPO) antibody ﬁnding
the rise of TSH levels was higher than in antibody negative patients.
This rise occurred in spite of having had higher magnesium levels at
the pre-stimulation time point. Serum levels of fT3 and fT4 did not
change in the sequential observation.
3.3.3. Magnesium and zinc levels
We found no relation between the number of previous pregnancies
or the number of IVF interventions and magnesium levels (ANOVA,
n.s.). We observed a signiﬁcant drop of magnesium levels in the IVF-
Fig. 1. Box plot ﬁgure showing the observed TSH levels in the 3 study groups, p = n.s.
Fig. 2. Box plot ﬁgure showing the observed magnesium levels in the 3 study groups, p = n.s.
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Table 1
Sequential changes of the biochemical parameters in early pregnancy.
Time points: _1: basal screening, _2: early pregnancy app. week 2–3, and _3: third
trimester.
IVF preg IVF no preg Spontaneous
AMH 36.0 ± 23.8 19.2 ± 12.9
TSH_1 1.48 ± 0.69 1.50 ± 0.82 1.49 ± 0.92
TSH_2 2.06 ± 1.06 1.44 ± 0.78
TSH_3 1.43 ± 0.57
fT3_1 4.18 ± 0.82 4.38 ± 0.67 4.32 ± 1.30
fT3_2 4.36 ± 0.69 4.34 ± 0.91
fT3_3 4.20 ± 0.56
fT4_1 13.41 ± 2.25 14.67 ± 2.87 13.74 ± 4.24
fT4_2 14.37 ± 2.24 14.12 ± 2.26
fT4_3 12.09 ± 1.52
Mg_1 0.95 ± 0.06 0.93 ± 0.06 0.95 ± 0.05
Mg_2 0.90 ± 0.08 0.92 ± 0.05
Mg_3 0.84 ± 0.07
Zn_1 13.12 ± 2.20 13.31 ± 2.34 13.53 ± 2.34
Zn_2 12.72 ± 2.52 12.88 ± 2.10
Zn_3 10.41 ± 1.54
SE_1 82.65 ± 25.06
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(Fig. 4). The changes were common to all stimulation protocols used.
There was a slight drop of magnesium levels in spontaneous pregnan-
cies from 0.95 ± 0.05 mmol/l to 0.92 ± 0.05 mmol/l (p = n.s.). In the
28th week of pregnancy we observed a drop in the concentration of
zinc and magnesium in the group with spontaneous pregnancies.
Magnesium levels in early pregnancy did not show any correlation
with E2 levels.
Zinc levels showed no signiﬁcant changes during early pregnancy
(13.12 ± 2.20 mmol/l to 12.72 ± 2.52 mmol/l in the IVF-pos group,
and 13.53 ± 2.34 mmol/l to 12.88 ± 2.10 mmol/l for the group ofFig. 3. Estradiol levels in respontaneous pregnancies). In this latter group a late drop to 10.41 ±
1.54 was observed. Zinc levels did not show any correlation to the
other parameters.
3.3.4. Correlation between estradiol and TSH levels in IVF-pos. and normal
pregnancies
There was a positive correlation between E2 levels and follow-up
TSH levels (r = 0.513, p b 0.001) in the IVF-pos. group. Such a relation
was not seen in normal pregnancies (Fig. 5).
3.3.5. fT4, TSH magnesium and anti-Müllerian hormone levels
after stimulation
At the early pregnancy time point the levels of fT4 levels showed a
positive correlation with TSH levels in the IVF-pos. group. The opposite
was observed in normal pregnancies. On the other hand fT3 levels
showed a negative correlation to TSH_2 in both groups (Fig. 6).
Combining the post-stimulation data on TSH and magnesium levels
we observed a tendency toward lower increase of TSH levels with
increasing magnesium concentration in the group of spontaneous
pregnancies (Fig. 8). In the IVF-pos. group this tendency was not so
apparent.
In the IVF-pos group a negative correlation between fT3 and anti-
Müllerian hormone levels was observed. Anti-Müllerian hormone
levels were found to correlate with the quality of follicles obtained
(p = 0.008).
4. Discussion
4.1. Magnesium and IVF outcome
Our study reveals new physiological aspects related to ART proce-
dures, thyroid function, magnesium, and pregnancy outcome.lation to IVF outcome.
Fig. 4. Sequential magnesium levels in the pregnancy groups.
Fig. 5. Correlation between estradiol and TSH levels in the follow-up pregnancy sample. IVF pregnancies.
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Fig. 6. Different correlation patterns between fT4_2 and TSH_2 in IVF pregnancies and in spontaneous pregnancies.
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levels of magnesium in the basal serum sample. In early pregnancy
magnesium levels fell signiﬁcantly while TSH levels tended to increase
in the IVF-pos. group. At the same time, an unexpected, previously not
described physiological relation, i.e. a positive correlation, was found
between fT4 and TSH which deﬁes prevailing dogmas in Endocrinolo-
gy. Anti-Müllerian hormone levels correlated to pregnancy success as
expected [25]. A new ﬁnding is the negative correlation found between
fT3 and anti-Müllerian hormone in the IVF-pos group. A lower TSH
increase in cases of spontaneous pregnancies was observed to go
along with higher magnesium levels.
Previous clinical studies have also dealtwith the issue of fecundity and
magnesium. In 2011 Bloom et al. looked at pre-conceptionalFig. 7. Trends to lower TSH levels in relation to increasiconcentrations ofmagnesium. The authors concluded that highermagne-
sium concentrations showed a trend toward an increased probability
for pregnancy [26]. Similar results on the beneﬁcial effects of selenium
and magnesium supplementation in improving fecundity were report-
ed already in 1994 [27]. These ﬁnding lend support to our observations.
4.2. Previous studies dealing with thyroid parameters and IVF
In the literature one can ﬁnd some clinical studies that have had a
similar design. In 2000 Muller et al. [28] described a drop of fT4 levels
and an increase of TSH levels. These results contrast with the slight in-
crease of fT4 whichwe have seen in IVF-pos and spontaneous pregnan-
cies. Themagnitude of TSH increase described byMullerwas larger thanng magnesium levels in spontaneous pregnancies.
Fig. 8. Negative correlation between anti-Müllerian hormone and fT3 in successful IVF pregnancies.
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Muller describe a heterogeneous population since the outcome of the
ART procedure was not given. The lack of relevance of thyroid antibod-
ies in relation to IVF success has been recently pointed out by Mintziori
et al. [7]. The authors concluded that new insights into this subject are
needed. Gracia et al. in 2012 [8] approached the question of changes
in thyroid function following ART procedures. The initial TSH rise
which they described was similar to the one we report here. The
data displayed in Fig. 1, upper panel deserves a special comment. The
graph describes increasing TSH levels in relation to thyroid peroxidase
antibody status. The rise in TSH is greater in thosewith positive serology
ﬁndings. Based on our own data on thyroid function andmagnesiumwe
hypothesize that those patients with positive serology could have
suboptimal magnesium levels [15,16]. In this paper we have shown
the opposite effect of magnesium concentration on the subsequent
TSH levels following ART (Fig. 7).
4.3. Estradiol and thyroid hormones
Our observations on serum estradiol levels and conception coincide
with those made by Grebb et al. [29]. We can conﬁrm the positive cor-
relation between estradiol and TSH levels following as was described
by Reinblatt [9]. Our data show a novel aspect of thyroid physiology,
i.e. a positive correlation between fT4 and TSH in early pregnancy in
the IVF-pos group. This situation can be seen as one of positive feedback
between the pituitary and the thyroid. Factors leading to this regulatory
switch could be the decrease ofmagnesium and the increase of estradiol
levels as both can inﬂuence thyroid function [11,13,30,31]. As a conse-
quence we propose that the increase of TSH during early pregnancy
following ART procedures could be considered to be a physiological ad-
aptation and not an expression of hypothyroidism. This special situation
is probably unique to IVF due to the supra-physiological condition being
achieved in IVF.Previous investigations have approached the question of thyroid
function in the setting of ART and IVF. Several of these studies rely on
the use of a recommended level of b2.5 mIU/l for basal TSH which
was termed “desirable” for pregnancy. In our clinical practice we
consider this recommendation as being extremely critical since it
comes from a consensus meeting where the authors attested that this
value did not have sufﬁcient clinical evidence [32]. Reh and coworkers
have also looked critically at this “desirable” TSH level [33]. They stated
in their conclusions that an increasing number of subjects would be
falsely classiﬁed as being hypothyroid. In a similar way we have also
commented recently on the inadequacy of such reference value [34].
Furthermore instituting thyroid hormone replacement alone has not
been found to be effective to inﬂuence IVF outcome [35]. Quite recently
other authors have also expressed similar opinions [36].
On energetic grounds mitochondrial biogenesis will require more
thyroid hormone which will then be converted into triiodothyronine.
Conversion of thyroxine to triiodothyronine in the cell requires sufﬁ-
cient selenium supply since the deiodinases are selenoproteins [37].
We hypothesize that the negative correlation seen between fT3 and
anti-Müllerian hormone could be depicting a common process related
to energy metabolism: high fT3 levels could compensate for lower
anti-Müllerian hormone concentrations and vice versa. Unfortunately,
we found no relevant literature on this topic.4.4. Previous investigations on magnesium levels and IVF
Previous studies in humans have also shown a decrease of Mg levels
during the IVF cycle [38]. In addition to this the authors found that
magnesium levels in the follicular ﬂuid were found to be higher than
in serum [38]. O'Shaughnessy working with the determination of ion-
ized cations showed that as estrogen levels rose, ionized magnesium
levels fell [39]. It should be recalled that the choice toworkwith ionized
203S. Stuefer et al. / BBA Clinical 3 (2015) 196–204magnesium determinations or not is an issue that depends on laborato-
ry facilities. The method we have chosen is easily available.
The distribution of magnesium in ovarian follicles during ART has
been shown by Silberstein et al. The authors proposed that the concen-
tration of cations in the follicular ﬂuid were the consequence of blood
transudation where larger follicles had the highest levels of magnesium
[40].
4.5. Hypothesis proposition: magnesium and telomerase in reproduction
What else can be of importance in face of low magnesium levels?
There is now a fascinating answer to this question. The Alturas have
demonstrated in 2014 that magnesium deﬁciency down regulates
telomerase [41]. Connecting these ﬁndings one can ﬁnd some relevant
data on telomerase and ovarian function in the literature. In 2011
Chen et al. proposed an unknown factor to be regulating telomerase in
granulosa cells. They speculated that telomerase could be related to tes-
tosterone [42]. On clinical grounds their clinical investigation showed
that higher levels of telomerase were related to higher implantation
and pregnancy rates (Fig. 2 in [42]). In a follow-up paper they discussed
that telomerase activity is more important for the prediction of preg-
nancy after IVF [43]. One could interpret these results in the light of
the ﬁndings of the Alturas [41]: sufﬁcientmagnesium ensures sufﬁcient
telomerase activity. Adding our results to this, we could also say that
sufﬁcient magnesium will maintain a normal thyroid function. High
levels of anti-Müllerian hormone appear to be an independent prognos-
tic factor.
5. Conclusions
In this present study we have observed that women with successful
pregnancies have higher blood levels of magnesium. For this reason it
appears sensible that magnesium levels should be optimized prior to
ART. This has to be complemented by relaxation techniques that will
reduce stress burden [14,15]. Anti-Müllerian hormone appears to be
an independent prognostic factor related to IVF success. Altogether we
interpret the changes in thyroid function during early pregnancy
following IVF as a regulatory mechanism oriented at maintaining
mitochondrial biogenesis via thyroid hormones. The parallel increase
of fT4 and TSH contradicts the general notion that it corresponds to hy-
pothyroidism. Finally if our speculative hypothesis proposing a relation
between magnesium and OXPHOS and telomerase can be conﬁrmed,






TSH thyroid stimulating hormone
ICSI intra cytoplasmatic sperm injection
FSH follicle stimulating hormone
hCG human chorionic gonadotropin
TESE testicular sperm extraction
AMH anti-Müllerian hormone
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